Skip to main content
logo
RegeneRx Biopharmaceuticals, Inc. (RGRX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Oct 29, 2025, 4:00 PM EDT

RGRX Revenue

RegeneRx Biopharmaceuticals had revenue of $19.19K in the quarter ending March 31, 2023, a decrease of -0.01%. This brings the company's revenue in the last twelve months to $76.76K. In the year 2022, RegeneRx Biopharmaceuticals had annual revenue of $76.76K.

Revenue (ttm)
76.76K
Revenue Growth
-0.00%
P/S Ratio
0.00
Revenue / Employee
25.59K
Employees
3
Market Cap
302.00

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202276.76K--
Dec 31, 202176.76K--
Dec 31, 202076.76K-1.00-
Dec 31, 201976.76K7.10K10.18%
Dec 31, 201869.67K13.02K22.97%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Jushi Holdings256.36M
Glass House Brands221.55M
Elite Pharmaceuticals105.45M
Silence Therapeutics27.17M
Nuo Therapeutics1.95M
Northwest Biotherapeutics1.09M
Revenue Rankings

RegeneRx Biopharmaceuticals News

More News